Chemical concern Bayer announced its intention to sell its non-core assets, such as brands of sunscreens and foot care products, as well as a division that produces veterinary drugs. This will allow the German company to focus its efforts on the core business, investing the funds received from asset sales. To improve business efficiency and reduce costs, Bayer plans to lay off about 12,000 employees by the end of 2021. Most of the layoffs will concern employees working in Germany. The company's management estimates that the effect of these measures, combined with the synergy from the merger with Monsanto, will bring Bayer 2,600 million euros per year.
US crude gains after White House says plans to intervene Saudi-Russia dispute20.03.2020
Gold drops out of its $1,600 support as investors sell to cover losses18.03.2020
German retailers' arms in the air as stores close13.03.2020
Wall Street sell-off sends double-digit falls in stocks as investors opt to cash